What is Clinical Trial Supply?

Clinical Trial Supply is the operational backbone that ensures investigational medicinal products (IMPs) are available for patients — in the right quantity, at the right time, and in full compliance with regulatory requirements.

It connects manufacturing, packaging, labelling, distribution and quality oversight into one controlled supply chain. Quality and compliance are not add-ons to this process — they are cornerstones embedded across every step.

miljø_facilitet-71
Patient Compliant Pack and Label Design

Why is it important?

When clinical trial supply works well, it is invisible. When it fails, it can delay trials, create financial impact, and directly affect patient safety and data integrity.

Clinical trial supply matters because timelines, patient safety and regulatory compliance depend on it. If clinical trial supply is not executed correctly and in full compliance, new therapies will not reach patients. It is therefore a fundamental enabler of medical innovation and the development of treatments across a broad spectrum of chronic and complex diseases.

What Does Clinical Trial Supply Cover?

Clinical trial supply spans the full lifecycle of investigational product handling — from production to final reconciliation.

Core components typically include:

Every component operates within a strict GxP framework. Documentation, traceability and audit readiness are continuous requirements.

Each element is interdependent. A delay in label approval affects packaging. A protocol amendment can trigger relabelling or additional production.

Clinical trial supply is therefore not a sequence of isolated tasks — it is a controlled, integrated, quality-driven system.

Supply strategy and forecasting

Comparator and ancillary sourcing

Packaging and labelling

QP certification and batch release

Logistics strategy and depot setup

Temperature-controlled supply chain

Accountability, returns, reconciliation and destruction

Ongoing quality oversight and documentation control

How Clinical Trial Supply Works in Practice

Clinical trial supply begins with the protocol

The trial protocol is translated into demand forecasts based on:

  • Dosing schedules
  • Treatment arms
  • Product shelf life
  • Country activation sequence

Forecasting is continuous, as recruitment rarely follows projections. Supply must adapt without creating delays or compliance risk.

From the outset, planning is governed by traceability, documentation control and risk management.

Packaging and Labelling

Before distribution, IMPs must meet strict regulatory requirements, including:

  • Country-specific label text
  • Blinding requirements
  • Import and QP release, where applicable
  • Compliance with applicable regulations

Packaging and labelling are high-risk activities. Errors in label content, version control or documentation can delay distribution, and ultimately patient treatment, until these are rectified.

Strong quality oversight ensures controlled documentation, clear approval workflows and full audit readiness.

Logistics Strategy and Depot Setup

Logistics strategy determines how product moves from manufacturing to clinical sites.

Key decisions include:

  • Global vs. local depot models
  • Centralised versus decentralised distribution
  • Temperature control requirements
  • Import/export and customs setup
  • Safety stock levels and resupply triggers

Quality and compliance remain central in logistics execution:

  • Temperature monitoring and excursion management
  • GDP compliance
  • Import/export documentation control
  • Vendor qualification and oversight

Distribution is not only about transport — it is about maintaining product integrity and regulatory compliance across borders and throughout the full trial lifecycle.

miljø_facilitet-67

Where Complexity Typically Increases

Clinical trial supply becomes more demanding when:

  • Additional countries are added mid-trial
  • Protocol changes occur
  • Shelf life is limited, and there is a risk this could be exceeded over the course of the trial
  • Multiple IMP strengths and/or comparators are involved
  • Comparator sourcing is constrained due to market shortages

Every added layer increases quality risk. More countries mean more regulatory nuances. More kit types increase the risk of allocation errors. Short shelf life puts pressure on timelines,  increases the complexity of inventory management, and may create a need for expiry-updating of products both in depots and at clinical sites.

The real discipline lies in balancing flexibility, operational speed and strict compliance control.

“Changes can be implemented quickly mid-trial.”

Protocol amendments, label updates or dosage adjustments often require coordinated changes across packaging, documentation, regulatory filings and distribution networks. What appears minor can trigger significant operational impact.

“If the product is manufactured, the hard part is done.”

Manufacturing is only one milestone. Packaging and labelling, QP certification, import, documentation and site distribution often determine the true critical path.

“All countries operate under the same rules.”

Regulatory, labelling and import requirements vary significantly across markets. Assuming uniformity across countries often leads to delays, re-labelling activities or customs holds that could have been avoided with early planning. Even in regions with harmonized regulations, such as the EU, country-specific nuances still exist and need to be accounted for in clinical trial supply strategies.

miljø_facilitet-28

What This Means in Reality

Clinical trial supply is not a background function. It is a strategic and quality-driven enabler of trial execution.

Well-designed and compliant supply models:

  • Protect patient dosing continuity
  • Safeguard product integrity
  • Maintain inspection readiness
  • Reduce waste and cost exposure
  • Reduce operational firefighting

The earlier quality and supply strategy are integrated into trial planning, the fewer compliance risks and operational surprises will emerge downstream.

16_22112021

How KLIFO Supports Clinical Trial Supply

At KLIFO, quality and compliance are cornerstones across the entire supply chain.

We support sponsors across the full clinical trial supply spectrum — from early strategy design to operational execution — supported by integrated in-house infrastructure:

  • GMP-compliant facility incorporating warehousing, packaging, labelling and distribution
  • Controlled temperature packaging and labelling suites (15-25oC, 2-8oC, -20oC) and processes (-80oC packaging over dry ice), and warehousing (15-25oC, 2-8oC, -20oC, -80oC)
  • Full global distribution setup, including a global network of approved in-country depots
  • Highly experienced teams in Operations, Quality and Project Management 
  • Full suite of QA/QP consultancy services, including final batch certification/release
Let’s talk
Rectangle 260007 (3)

How KLIFO Supports Clinical Trial Supply

This structure ensures:

  • Strong quality oversight
  • Short decision paths
  • Reduced vendor handovers
  • Clear accountability

Our approach combines:

  • Risk-based planning
  • Operational execution
  • Regulatory alignment
  • Integrated QA governance
  • Proactive scenario management

We are our customers’ Clinical Trial Supply experts — so they can focus on clinical and scientific objectives, confident that supply and compliance are fully aligned.

Get in touch with KLIFO

Get in touch with us

Through collaboration, we can harness our combined expertise and ensure proper project implementation to ensure that your organisation benefits in both the short and long term.

Get in contact